One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: An uncertain balance between risks and benefits
- 1 August 2005
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 130 (2) , 416-425
- https://doi.org/10.1016/j.jtcvs.2004.11.022
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II TrialJournal of Clinical Oncology, 2003
- Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patientsEuropean Journal of Cardio-Thoracic Surgery, 2002
- Long-Term Results of Combined-Modality Therapy in Resectable Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a reviewEuropean Journal of Cardio-Thoracic Surgery, 1998
- Pulmonary embolism: a frequent cause of acute fatality after lung resectionEuropean Journal of Cardio-Thoracic Surgery, 1996
- Results of cancer and leukemia group B protocol 8935The Journal of Thoracic and Cardiovascular Surgery, 1995
- Neoadjuvant therapy: A novel and effective treatment for stage IIIb non-small cell lung cancerThe Annals of Thoracic Surgery, 1994
- Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancerThe Annals of Thoracic Surgery, 1994
- Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patientsThe Annals of Thoracic Surgery, 1993
- Postoperative complications after combined neoadjuvant treatment of lung cancerThe Annals of Thoracic Surgery, 1993